(Q40956265)

25 September 2017

title

Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one (English)

1 reference

25 September 2017

Edwards JP

1

1 reference

25 September 2017

Higuchi RI

2

1 reference

25 September 2017

Winn DT

3

1 reference

25 September 2017

Pooley CL

4

1 reference

25 September 2017

Caferro TR

5

1 reference

25 September 2017

Hamann LG

6

1 reference

25 September 2017

Zhi L

7

1 reference

25 September 2017

Marschke KB

8

1 reference

25 September 2017

Goldman ME

9

1 reference

25 September 2017

Jones TK

10

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Bioorganic & Medicinal Chemistry Letters

25 September 2017

published in

1 reference

25 September 2017

volume

9

1 reference

25 September 2017

issue

7

1 reference

25 September 2017

page(s)

1003-1008

1 reference

Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Intracellular receptors and signal transducers and activators of transcription superfamilies: novel targets for small-molecule drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Anti-Androgenicity of Flutamide and its Metabolite Sch 16423

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Biological aspects of antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Current clinical studies with a new nonsteroidal antiandrogen, Casodex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Efficacy and tolerability of Casodex in patients with advanced prostate cancer. International Casodex Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Discovery of nonsteroidal androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Interaction of glucocorticoid analogues with the human glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Discovery and preliminary SAR studies of a novel, nonsteroidal progesterone receptor antagonist pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900118-3

7 January 2021

10.1016/S0960-894X(99)00118-3

Identifiers

DOI

1 reference

25 September 2017

1 reference